Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient

Aging Clin Exp Res. 2015 Feb;27(1):85-7. doi: 10.1007/s40520-014-0235-x. Epub 2014 Apr 30.

Authors

N C Chilelli¹, S Burlina, G Sartore, A Lapolla

Affiliation

¹ Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.

PMID: 24781833
DOI: 10.1007/s40520-014-0235-x

No abstract available

Publication types

Case Reports

MeSH terms

Adamantane / analogs & derivatives*
Adamantane / therapeutic use
Aged
Blood Glucose / analysis*
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
Female
Humans
Medication Adherence*
Nitriles / therapeutic use*
Pyrrolidines / therapeutic use*
Vildagliptin

Substances

Blood Glucose
Dipeptidyl-Peptidase IV Inhibitors
Nitriles
Pyrrolidines
Vildagliptin
Adamantane